Memantine exacerbates myoclonic jerks in a rat model of posthypoxic myoclonus

Brain Research

Volumn 1343, Issue , 2010, Pages 194-198

  Tai, Kwok Keung ^a   Truong, Daniel D ^b  

^a LONG BEACH MEMORIAL MEDICAL CENTER   (United States)

^b Parkinson's and Movement Disorder Institute   (United States)

Author keywords

Cardiac arrest; Cerebellum; Cerebral hypoxia; Cerebral ischemia; Posthypoxic myoclonus; Purkinje cell

Indexed keywords

MEMANTINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN HYPOXIA; BRAIN ISCHEMIA; CEREBELLUM; CONTROLLED STUDY; DISEASE EXACERBATION; MALE; MYOCLONUS; NERVE CELL DEGENERATION; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PURKINJE CELL; RAT;

ANIMALS; CEREBELLUM; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; HYPOXIA, BRAIN; MALE; MEMANTINE; MYOCLONUS; NERVE DEGENERATION; PURKINJE CELLS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE;

ANIMALIA; RATTUS;

EID: 77953620121     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.04.058     Document Type: Article

References (27)

1. Bhatia K.P., Brown P., Gregory R., Lennox G.G., Manji H., Thompson P.D., Ellison D.W., and Marsden C.D. Progressive myoclonic ataxia associated with coeliac disease. The myoclonus is of cortical origin, but the pathology is in the cerebellum. Brain 118 Pt 5 (1995) 1087-1093
2. Brorson J.R., Manzolillo P.A., and Miller R.J. Ca2+ entry via AMPA/KA receptors and excitotoxicity in cultured cerebellar Purkinje cells. J. Neurosci. 14 (1994) 187-197
3. Brorson J.R., Manzolillo P.A., Gibbons S.J., and Miller R.J. AMPA receptor desensitization predicts the selective vulnerability of cerebellar Purkinje cells to excitotoxicity. J. Neurosci. 15 (1995) 4515-4524
4. Chadwick D., Jenner P., Harris R., Reynolds E.H., and Marsden C.D. Manipulation of brain serotonin in the treatment of myoclonus. Lancet 2 (1975) 434-435
5. De Lean J., Richardson J.C., and Hornykiewicz O. Beneficial effects of serotonin precursors in postanoxic action myoclonus. Neurology 26 (1976) 863-868
6. Fahn S. Post-anoxic action myoclonus: improvement with valproic acid. N. Engl. J. Med. 299 (1978) 313-314
7. Fahn S., Marsden C.D., and Van Woert M.H. Definition and classification of myoclonus. Adv. Neurol. 43 (1986) 1-5
8. Goldberb M.A., and Dorman J.D. Intention myoclonus: successful treatment with clonazepam. Neurology 26 (1976) 24-26
9. Hallett M., and Wilkins D.E. Myoclonus in Alzheimer's disease and minipolymyoclonus. Adv. Neurol. 43 (1986) 399-405
10. Hwang E.C., and Van Woert M.H. DDT-induced myoclonus: serotonin and alpha noradrenergic interaction. Res. Commun. Chem. Pathol. Pharmacol. 23 (1979) 257-266
11. Kawai K., Penix L.P., Kawahara N., Ruetzler C.A., and Klatzo I. Development of susceptibility to audiogenic seizures following cardiac arrest cerebral ischemia in rats. J. Cereb. Blood Flow Metab. 15 (1995) 248-258
12. Lance J.W., and Adams R.D. The syndrome of intention or action myoclonus as a sequel to hypoxic encephalopathy. Brain 86 (1963) 111-136
13. Matsumoto R.R., Hussong M.J., and Truong D.D. Effects of selective serotonergic ligands on posthypoxic audiogenic myoclonus. Mov. Disord. 10 (1995) 615-621
14. Papageorgiou S.G., Kontaxis T., Antelli A., and Kalfakis N. Exacerbation of myoclonus by memantine in a patient with Alzheimer disease. J. Clin. Psychopharmacol. 27 (2007) 407-408
15. Placantonakis D.G., Schwarz C., and Welsh J.P. Serotonin suppresses subthreshold and suprathreshold oscillatory activity of rat inferior olivary neurones in vitro. J. Physiol. 524 Pt 3 (2000) 833-851
16. Pratt J.A., Rothwell J., Jenner P., and Marsden C.D. Myoclonus in the rat induced by p, p′-DDT and the role of altered monoamine function. Neuropharmacology 24 (1985) 361-373
17. Rammes G., Rupprecht R., Ferrari U., Zieglgansberger W., and Parsons C.G. The N-methyl-d-aspartate receptor channel blockers memantine, MRZ 2/579 and other amino-alkyl-cyclohexanes antagonise 5-HT(3) receptor currents in cultured HEK-293 and N1E-115 cell systems in a non-competitive manner. Neurosci. Lett. 306 (2001) 81-84
18. Reiser G., Binmoller F.J., and Koch R. Memantine (1-amino-3, 5-dimethyladamantane) blocks the serotonin-induced depolarization response in a neuronal cell line. Brain Res. 443 (1988) 338-344
19. Rothman S.M., and Olney J.W. Excitotoxicity and the NMDA receptor-still lethal after eight years. Trends Neurosci. 18 (1995) 57-58
20. Tai K.K., and Truong D.D. Post-hypoxic myoclonus induces Fos expression in the reticular thalamic nucleus and neurons in the brainstem. Brain Res. 1059 (2005) 122-128
21. Tai K.K., and Truong D.D. Ketogenic diet prevents seizure and reduces myoclonic jerks in rats with cardiac arrest-induced cerebral hypoxia. Neurosci. Lett. 425 (2007) 34-38
22. Tai K.K., and Truong D.D. NMDA receptor-mediated excitotoxicity contributes to the cerebral hypoxic injury of a rat model of posthypoxic myoclonus. Brain Res. 1133 (2007) 209-215
23. Tai K.K., Nguyen N., Pham L., and Truong D.D. Ketogenic diet prevents cardiac arrest-induced cerebral ischemic neurodegeneration. J. Neural. Transm. 115 (2008) 1011-1017
24. Truong D.D., Matsumoto R.R., Schwartz P.H., Hussong M.J., and Wasterlain C.G. Novel rat cardiac arrest model of posthypoxic myoclonus. Mov. Disord. 9 (1994) 201-206
25. Truong D.D., Kirby M., Kanthasamy A., and Matsumoto R.R. Posthypoxic myoclonus animal models. Adv. Neurol. 89 (2002) 295-306
26. Van Woert M.H., Rosenbaum D., Howieson J., and Bowers Jr. M.B. Long-term therapy of myoclonus and other neurologic disorders with L-5-hydroxytryptophan and carbidopa. N. Engl. J. Med. 296 (1977) 70-75
27. Welsh J.P., Chang B., Menaker M.E., and Aicher S.A. Removal of the inferior olive abolishes myoclonic seizures associated with a loss of olivary serotonin. Neuroscience 82 (1998) 879-897